Clinical Trial Update: Safety Study of MP4CO in Adult Sickle Cell Patients [Phase 1]

View source ↗

Summary

Phase 1 safety study of MP4CO in adults with sickle cell disease has completed; this update summarizes the trial status and safety assessment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemoglobin Sc Disease
• Sickle Cell Disease

Drugs mentioned

• MP4CO

Snippet

Sponsor: Sangart | Conditions: Anemia, Sickle Cell, Sickle Cell Anemia | Phase 1 | Status: COMPLETED